Xiaolu Su

1.3k total citations
28 papers, 879 citations indexed

About

Xiaolu Su is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiaolu Su has authored 28 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiaolu Su's work include Coronary Interventions and Diagnostics (17 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (6 papers). Xiaolu Su is often cited by papers focused on Coronary Interventions and Diagnostics (17 papers), Cardiac Imaging and Diagnostics (9 papers) and Cardiac Valve Diseases and Treatments (6 papers). Xiaolu Su collaborates with scholars based in United States, China and United Kingdom. Xiaolu Su's co-authors include Gregg W. Stone, Wai‐Fung Cheong, Dean J. Kereiakes, Krishnankutty Sudhir, Poornima Sood, Jennifer Jones-McMeans, Stephen G. Ellis, Zhen Zhang, Yoshinobu Onuma and Patrick W. Serruys and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Xiaolu Su

27 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolu Su United States 15 774 592 243 216 70 28 879
Peter W. Danse Netherlands 19 933 1.2× 860 1.5× 264 1.1× 256 1.2× 42 0.6× 55 1.1k
Mariano Albertal Argentina 14 490 0.6× 379 0.6× 168 0.7× 294 1.4× 31 0.4× 67 642
Masaki Awata Japan 14 893 1.2× 599 1.0× 397 1.6× 324 1.5× 51 0.7× 40 1.0k
J Hamburger Netherlands 16 662 0.9× 610 1.0× 223 0.9× 326 1.5× 51 0.7× 43 877
Javier Cuesta Spain 17 696 0.9× 642 1.1× 305 1.3× 256 1.2× 28 0.4× 105 918
Gaku Nakazawa Japan 14 627 0.8× 402 0.7× 292 1.2× 352 1.6× 89 1.3× 44 824
Dragan Sagić Serbia 16 596 0.8× 447 0.8× 343 1.4× 105 0.5× 80 1.1× 73 822
Patrick Serruys Netherlands 11 798 1.0× 575 1.0× 254 1.0× 559 2.6× 39 0.6× 14 966
Peiman Jamshidi Switzerland 20 757 1.0× 904 1.5× 413 1.7× 211 1.0× 51 0.7× 56 1.2k
Daniel B. Fram United States 16 439 0.6× 394 0.7× 146 0.6× 137 0.6× 92 1.3× 42 711

Countries citing papers authored by Xiaolu Su

Since Specialization
Citations

This map shows the geographic impact of Xiaolu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolu Su more than expected).

Fields of papers citing papers by Xiaolu Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolu Su. The network helps show where Xiaolu Su may publish in the future.

Co-authorship network of co-authors of Xiaolu Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolu Su. A scholar is included among the top collaborators of Xiaolu Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolu Su. Xiaolu Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qian, Qingjie Chen, Hong Wei, et al.. (2025). Targeting the BAG2/CHIP axis promotes gastric cancer apoptosis by blocking apoptosome assembly. Frontiers in Immunology. 16. 1578416–1578416.
2.
Li, Qingchao, et al.. (2024). HER2 Affects the Biological Behaviours of Bladder Cancer Cells and is Closely Associated with the Progression and Prognosis of Bladder Cancer. Archivos Españoles de Urología. 77(1). 79–79. 2 indexed citations
3.
Yang, Xiaoping, Xiaolu Su, Zirui Wang, et al.. (2023). ULBP2 is a biomarker related to prognosis and immunity in colon cancer. Molecular and Cellular Biochemistry. 478(10). 2207–2219. 9 indexed citations
4.
Guo, Changan, et al.. (2022). NPM1 is a diagnostic and prognostic biomarker associated with the clinicopathological characteristics of gastric cancer. Neoplasma. 69(4). 965–975. 6 indexed citations
5.
Yang, Xiaoping, et al.. (2022). Constructed the ceRNA network and predicted a FEZF1-AS1/miR-92b-3p/ZIC5 axis in colon cancer. Molecular and Cellular Biochemistry. 478(5). 1083–1097. 4 indexed citations
6.
Su, Xiaolu, et al.. (2021). Liq_ccRCC: Identification of Clear Cell Renal Cell Carcinoma Based on the Integration of Clinical Liquid Indices. Frontiers in Oncology. 10. 605769–605769. 1 indexed citations
7.
Patel, Chetan B., Laura Blue, B. Cagliostro, et al.. (2020). Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. The Journal of Heart and Lung Transplantation. 39(8). 774–781. 54 indexed citations
8.
Mao, Lei, Jun Li, Fang Wang, et al.. (2020). Esophageal tuberculosis complicated with intestinal tuberculosis: A case report. World Journal of Clinical Cases. 8(3). 645–651. 2 indexed citations
9.
Xu, Bo, Yuejin Yang, Yaling Han, et al.. (2018). Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial. EuroIntervention. 14(5). e554–e561. 25 indexed citations
10.
Yang, Yuejin, Yaling Han, Yong Huo, et al.. (2015). Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease. Journal of the American College of Cardiology. 66(21). 2298–2309. 182 indexed citations
11.
Kereiakes, Dean J., Stephen G. Ellis, Jeffrey J. Popma, et al.. (2015). Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial. American Heart Journal. 170(4). 641–651.e3. 30 indexed citations
12.
Applegate, Robert J., James Hermiller, Paul Gordon, et al.. (2012). Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention. 7(9). 1030–1042. 3 indexed citations
13.
Kereiakes, Dean J., Donald E. Cutlip, Robert J. Applegate, et al.. (2010). Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents. Journal of the American College of Cardiology. 56(25). 2084–2089. 67 indexed citations
14.
Caixeta, Adriano, Alexandra J. Lansky, Patrick W. Serruys, et al.. (2010). Clinical Follow-Up 3 Years After Everolimus- and Paclitaxel-Eluting Stents. JACC: Cardiovascular Interventions. 3(12). 1220–1228. 37 indexed citations
15.
Kereiakes, Dean J., Krishnankutty Sudhir, James Hermiller, et al.. (2010). COMPARISON OF EVEROLIMUS-ELUTING AND PACLITAXEL-ELUTING CORONARY STENTS IN PATIENTS UNDERGOING MULTI-VESSEL STENTING: POOLED ANALYSIS FROM THE SPIRIT III AND SPIRIT IV RANDOMIZED TRIALS. Journal of the American College of Cardiology. 55(10). A140.E1317–A140.E1317. 1 indexed citations
16.
Kereiakes, Dean J., Krishnankutty Sudhir, James Hermiller, et al.. (2010). Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients Undergoing Multilesion and Multivessel Intervention. JACC: Cardiovascular Interventions. 3(12). 1229–1239. 27 indexed citations
17.
Nikolsky, Eugenia, Alexandra J. Lansky, Krishnankutty Sudhir, et al.. (2009). SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease. American Heart Journal. 158(4). 520–526.e2. 36 indexed citations
18.
Lansky, Alexandra J., Vivian G. Ng, Ecaterina Cristea, et al.. (2009). Gender‐based evaluation of the XIENCE V™ everolimus‐eluting coronary stent system:. Catheterization and Cardiovascular Interventions. 74(5). 719–727. 34 indexed citations
19.
20.
Lefèvre, Thierry, John A. Ormiston, Giulio Guagliumi, et al.. (2005). The FRONTIER Stent Registry. Journal of the American College of Cardiology. 46(4). 592–598. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter W. Danse Breakdown of academic impact, for papers by Mariano Albertal Breakdown of academic impact, for papers by Masaki Awata Breakdown of academic impact, for papers by J Hamburger Breakdown of academic impact, for papers by Javier Cuesta Breakdown of academic impact, for papers by Gaku Nakazawa Breakdown of academic impact, for papers by Dragan Sagić Breakdown of academic impact, for papers by Patrick Serruys Breakdown of academic impact, for papers by Peiman Jamshidi Breakdown of academic impact, for papers by Daniel B. Fram
Rankless by CCL
2026